Discover 1,248 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nashville offers many research opportunities for conditions such as diabetes, cardiovascular disease, and arthritis, giving participants access to innovative treatments and cutting-edge medical care. The city’s leading healthcare institutions are actively recruiting healthy volunteers for paid research studies, as well as individuals seeking trials for specific health concerns.
Filter
2
Filter results
Results: 1,248
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
for
Familial Adenomatous Polyposis
Location: Nashville TN, St Louis MO, Dallas TX, Houston TX,
Sponsor: Recursion Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT05552755
Phase1, Phase2, Recruiting
Suture Repair vs Mesh Repair for Incisional Hernia
for
Incisional Hernia
Location: Nashville TN, Chicago IL, Cleveland OH, Gainesville FL
Sponsor: Clayton Petro
Sex: All
Age: 18+
Code: NCT05599750
Recruiting
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans
for
Endothelial Dysfunction
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18 - 60
Code: NCT04769206
Phase1, Phase2, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Nashville TN, Birmingham AL, Memphis TN, Atlanta GA,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07304089
Phase2, Recruiting
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
for
Cardiac Failure, Graft Rejection
Location: Nashville TN, Charleston SC, Dallas TX, Boston MA,
Sponsor: Northwestern University
Sex: All
Age: 18 - 70+
Code: NCT06939751
Recruiting
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
for
Ig-E Mediated Food Allergy
Location: Nashville TN, Atlanta GA, Cincinnati OH, Little Rock AR,
Sponsor: RAPT Therapeutics, Inc.
Sex: All
Age: 12 - 55
Code: NCT07220811
Phase2, Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
for
Metastatic Gastric Adenocarcinoma,
Location: Nashville TN, Bridgeton MO, Hinsdale IL, Chicago IL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07043400
Phase3, Recruiting
A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1